# A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

> **NCT06721494** · PHASE2 · RECRUITING · sponsor: **Clear Scientific, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Methamphetamine Intoxication
- Methamphetamine Disorders
- Methamphetamine Abuse

## Interventions

- **DRUG:** Methamphetamine
- **DRUG:** Sterile Saline
- **DRUG:** CS-1103

## Key facts

- **NCT ID:** NCT06721494
- **Lead sponsor:** Clear Scientific, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-05
- **Primary completion:** 2026-09-04
- **Final completion:** 2026-09-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06721494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06721494, "A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06721494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*